CHIA-TER CHAOJENQ-WEN HUANGCHUNG-JEN YEN2020-10-142020-10-1420130896-8608https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885821688&doi=10.3747%2fpdi.2013.00009&partnerID=40&md5=6dc7f0ac4a92ccdb1c545df4c87af76fhttps://scholars.lib.ntu.edu.tw/handle/123456789/516901[SDGs]SDG2[SDGs]SDG3C reactive protein; cefazolin; ceftazidime; creatinine; gentamicin; hemoglobin; linezolid; penicillin derivative; quinoline derived antiinfective agent; tetracycline; vancomycin; abdominal pain; aged; antibiotic resistance; antibiotic therapy; bacterium contamination; bacterium culture; bacterium identification; case report; continuous ambulatory peritoneal dialysis; Corynebacterium; Corynebacterium infection; corynebacterium jeikeium; dialysate; disease severity; drug efficacy; drug response; effluent; female; hemodialysis; human; immunocompromised patient; infection risk; kidney failure; letter; leukocyte count; nonhuman; peritoneal dialysis; peritonitis; priority journal; Aged, 80 and over; Anti-Bacterial Agents; Catheters, Indwelling; Corynebacterium; Corynebacterium Infections; Device Removal; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitisletter10.3747/pdi.2013.00009241330862-s2.0-84885821688